Artigos de revistas: "Interleukin-12"

1

Leonard, Patricia, e Sanjiv Sur. "Interleukin-12". BioDrugs 17, n.º 1 (2003): 1–7. http://dx.doi.org/10.2165/00063030-200317010-00001.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

2

&NA;. "Interleukin-12". Inpharma Weekly &NA;, n.º 1124 (fevereiro de 1998): 7. http://dx.doi.org/10.2165/00128413-199811240-00013.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

3

Trinchieri, Giorgio. "Interleukin-12". Clinical Immunotherapeutics 3, n.º 4 (abril de 1995): 262–70. http://dx.doi.org/10.1007/bf03259278.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

4

Clinton, Steven K., Eduardo Canto e Michael A. O'Donnell. "INTERLEUKIN-12". Urologic Clinics of North America 27, n.º 1 (fevereiro de 2000): 147–55. http://dx.doi.org/10.1016/s0094-0143(05)70242-1.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

5

Weiner, David. "Plasmid Interleukin 12". AIDS 14, n.º 12 (agosto de 2000): 1759–60. http://dx.doi.org/10.1097/00002030-200008180-00010.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

6

Leng, S. X., e J. A. Elias. "Interleukin-11 inhibits macrophage interleukin-12 production." Journal of Immunology 159, n.º 5 (1 de setembro de 1997): 2161–68. http://dx.doi.org/10.4049/jimmunol.159.5.2161.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

Resumo:

Abstract IL-12 is a heterodimeric cytokine produced by phagocytic and other cells with important physiologic and pathologic properties. Regulated IL-12 production is crucial for the generation of protective Th1 responses to infectious agents. In contrast, IL-12 excess contributes to the pathogenesis of a variety of autoimmune and inflammatory disorders. To further understand the processes regulating IL-12 production, we determined whether IL-11 regulated monocyte/macrophage production of this cytokine moiety. IL-11 did not alter the IL-12 (p70) production of unstimulated THP-1 monocytic cells or human blood monocytes. It did, however, inhibit, in a dose-dependent fashion, the IL-12 production of IFN-gamma plus Staphylococcus aureus Cowan strain 1-stimulated THP-1 cells and stimulated blood monocytes. This inhibition of IL-12 protein production was associated with a proportionate decrease in IL-12 p35 and p40 mRNA accumulation. Nuclear run-on assays revealed comparable decreases in IL-12 p35 and p40 gene transcription. IL-11 did not similarly regulate monocyte/macrophage production of IL-8 or macrophage inflammatory protein-1alpha (MIP-1alpha) and IL-6 did not similarly inhibit IL-12 elaboration. These studies demonstrate that IL-11 is a potent inhibitor of monocyte/macrophage IL-12 production and that this inhibitory effect is, at least in part, transcriptionally mediated. They also demonstrate that this inhibition is not the result of a generalized suppression of macrophage effector function and that the ability to inhibit monocyte/macrophage IL-12 production is not a generalized property of all IL-6-type cytokines.

7

Fox, Robert J., e Abdolmohamad M. Rostami. "Anti???Interleukin-12 Antibody". BioDrugs 13, n.º 4 (abril de 2000): 233–41. http://dx.doi.org/10.2165/00063030-200013040-00002.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

8

&NA;. "Interleukin-12 trial halted". Reactions Weekly &NA;, n.º 556 (junho de 1995): 2. http://dx.doi.org/10.2165/00128415-199505560-00003.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

9

&NA;. "Interleukin-12 studies continue". Reactions Weekly &NA;, n.º 558 (julho de 1995): 2. http://dx.doi.org/10.2165/00128415-199505580-00003.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

10

&NA;. "Interleukin-12 trial halted". Inpharma Weekly &NA;, n.º 992 (junho de 1995): 21. http://dx.doi.org/10.2165/00128413-199509920-00047.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

11

&NA;. "Interleukin-12 studies continue". Inpharma Weekly &NA;, n.º 994 (julho de 1995): 21. http://dx.doi.org/10.2165/00128413-199509940-00042.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

12

KATIYAR, S. "Interleukin-12 and photocarcinogenesis". Toxicology and Applied Pharmacology 224, n.º 3 (1 de novembro de 2007): 220–27. http://dx.doi.org/10.1016/j.taap.2006.11.017.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

13

Maguire, H. C. "INTERLEUKIN 12 AS IMMUNOADJUVANT". Journal of Immunotherapy 16, n.º 3 (outubro de 1994): 240. http://dx.doi.org/10.1097/00002371-199410000-00032.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

14

de Rie, M. A. "Interleukin 12 and Psoriasis". Dermatology 199, n.º 2 (1999): 101. http://dx.doi.org/10.1159/000018213.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

15

Trinchieri, Giorgio, e Franca Gerosa. "Immunoregulation by interleukin-12". Journal of Leukocyte Biology 59, n.º 4 (abril de 1996): 505–11. http://dx.doi.org/10.1002/jlb.59.4.505.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

16

Ma, X., A. D'Andrea, M. Kubin, M. Aste-Amezaga, A. Sartori, J. Monteiro, L. Showe, M. Wysocka e G. Trinchieri. "Production of interleukin-12". Research in Immunology 146, n.º 7-8 (setembro de 1995): 432–38. http://dx.doi.org/10.1016/0923-2494(96)83012-4.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

17

Crutcher, J. M., M. M. Stevenson, M. Sedegah e S. L. Hoffman. "Interleukin-12 and malaria". Research in Immunology 146, n.º 7-8 (setembro de 1995): 552–59. http://dx.doi.org/10.1016/0923-2494(96)83031-8.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

18

Tsai, I. San, Chi-Cheng Tsai, Ya-Ping Ho, Kun-Yen Ho, Yi-Min Wu e Chun-Cheng Hung. "Interleukin-12 and interleukin-16 in periodontal disease". Cytokine 31, n.º 1 (julho de 2005): 34–40. http://dx.doi.org/10.1016/j.cyto.2005.02.007.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

19

BACON, CHRIS M., SARAH S. CHO e JOHN J. O'SHEA. "Signal Transduction by Interleukin-12 and Interleukin-2." Annals of the New York Academy of Sciences 795, n.º 1 Interleukin 1 (outubro de 1996): 41–59. http://dx.doi.org/10.1111/j.1749-6632.1996.tb52654.x.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

20

Torti, Dorothea C., e Steven R. Feldman. "Interleukin-12, interleukin-23, and psoriasis: Current prospects". Journal of the American Academy of Dermatology 57, n.º 6 (dezembro de 2007): 1059–68. http://dx.doi.org/10.1016/j.jaad.2007.07.016.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

21

Sánchez, E., S. Morales, L. Paco, M. A. López-Nevot, C. Hidalgo, J. Jiménez-Alonso, B. Torres et al. "Interleukin 12 (IL12B), interleukin 12 receptor (IL12RB1) and interleukin 23 (IL23A) gene polymorphism in systemic lupus erythematosus". Rheumatology 44, n.º 9 (31 de maio de 2005): 1136–39. http://dx.doi.org/10.1093/rheumatology/keh697.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

22

Mattner, Frank, Susanne Fischer, Stefanie Guckes, Shenchu Jin, Hildegard Kaulen, Edgar Schmitt, Erwin Rüde e Tieno Germann. "The interleukin-12 subunit p40 specifically inhibits effects of the interleukin-12 heterodimer". European Journal of Immunology 23, n.º 9 (setembro de 1993): 2202–8. http://dx.doi.org/10.1002/eji.1830230923.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

23

Orozco, Gisela, Miguel A. González-Gay, Laura Paco, Miguel A. López-Nevot, Manuel Guzmán, Dora Pascual-Salcedo, Alejandro Balsa e Javier Martín. "Interleukin 12 (IL12B) and Interleukin 12 Receptor (IL12RB1) Gene Polymorphisms in Rheumatoid Arthritis". Human Immunology 66, n.º 6 (junho de 2005): 710–14. http://dx.doi.org/10.1016/j.humimm.2005.02.004.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

24

Tahara, H., L. Zitvogel, W. J. Storkus, T. G. McKinney, P. D. Robbins e M. T. Lotze. "CANCER GENE THERAPY USING INTERLEUKIN-12 (IL-12)". Journal of Immunotherapy 16, n.º 3 (outubro de 1994): 245. http://dx.doi.org/10.1097/00002371-199410000-00053.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

25

Lu, Zhiyu, Keye Xu, Xiaoying Wang, Yan Li e Mingcai Li. "Interleukin 39: a new member of interleukin 12 family". Central European Journal of Immunology 45, n.º 2 (2020): 214–17. http://dx.doi.org/10.5114/ceji.2020.97911.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

26

Rentzos, M., C. Nikolaou, E. Andreadou, G. P. Paraskevas, A. Rombos, M. Zoga, A. Tsoutsou, F. Boufidou, E. Kapaki e D. Vassilopoulos. "Circulating interleukin-10 and interleukin-12 in Parkinson’s disease". Acta Neurologica Scandinavica 119, n.º 5 (maio de 2009): 332–37. http://dx.doi.org/10.1111/j.1600-0404.2008.01103.x.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

27

&NA;. "Interleukin-12 toxicity mystery solved". Reactions Weekly &NA;, n.º 580 (dezembro de 1995): 2. http://dx.doi.org/10.2165/00128415-199505800-00002.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

28

&NA;. "Interleukin-12 toxicity mystery solved". Inpharma Weekly &NA;, n.º 1016 (dezembro de 1995): 21. http://dx.doi.org/10.2165/00128413-199510160-00046.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

29

Romani, L., P. Puccetti e F. Bistoni. "Interleukin-12 in infectious diseases." Clinical Microbiology Reviews 10, n.º 4 (outubro de 1997): 611–36. http://dx.doi.org/10.1128/cmr.10.4.611.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

Resumo:

Interleukin-12 (IL-12) is a potent immunoregulatory cytokine that is crucially involved in a wide range of infectious diseases. In several experimental models of bacterial, parasitic, viral, and fungal infection, endogenous IL-12 is required for early control of infection and for generation and perhaps maintenance of acquired protective immunity, directed by T helper type 1 (Th1) cells and mediated by phagocytes. Although the relative roles of IL-12 and gamma interferon in Th1-cell priming may be to a significant extent pathogen dependent, common to most infections is that IL-12 regulates the magnitude of the gamma interferon response at the initiation of infection, thus potentiating natural resistance, favoring Th1-cell development; and inhibiting Th2 responses. Treatment of animals with IL-12, either alone or as a vaccine adjuvant, has been shown to prevent disease by many of the same infectious agents, by stimulating innate resistance or promoting specific reactivity. Although IL-12 may enhance protective memory responses in vaccination or in combination with antimicrobial chemotherapy, it is yet unclear whether exogenous IL-12 can alter established responses in humans. Continued investigation into the possible application of IL-12 therapy to human infections is warranted by the role of the cytokine in inflammation, immunopathology, and autoimmunity.

30

Romani, L., P. Puccetti e F. Bistoni. "Interleukin-12 in infectious diseases." Clinical microbiology reviews 10, n.º 4 (1997): 611–36. http://dx.doi.org/10.1128/cmr.10.4.611-636.1997.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

31

Bashyam, Hema. "Interleukin-12: A master regulator". Journal of Experimental Medicine 204, n.º 5 (7 de maio de 2007): 969. http://dx.doi.org/10.1084/jem.2045fta.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

Resumo:

Early resistance to pathogens requires a swift response from NK cells. In 1989, Giorgio Trinchieri identified an NK growth factor and activator, later called interleukin-12 (IL-12). This discovery helped reveal the regulatory link between innate and adaptive immunity.

32

Adorini, Luciano. "Interleukin 12 and autoimmune diabetes". Nature Genetics 27, n.º 2 (fevereiro de 2001): 131–32. http://dx.doi.org/10.1038/84732.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

33

Sacks, G. P., D. Scott, H. Tivnann, T. Mire-Sluis, I. L. Sargent e C. W. G. Redman. "Interleukin-12 and pre-eclampsia". Journal of Reproductive Immunology 34, n.º 2 (setembro de 1997): 155–58. http://dx.doi.org/10.1016/s0165-0378(97)00028-4.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

34

Bryan, Dani-Louise, Joanna S. Hawkes e Robert A. Gibson. "Interleukin-12 in Human Milk". Pediatric Research 45, n.º 6 (junho de 1999): 858–59. http://dx.doi.org/10.1203/00006450-199906000-00013.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

35

Sturmhoefel, K., K. Lee, M. O. Toole, H. M. Swiniarski, A. J. Dorner e S. F. Wolf(xc*). "Interleukin 12 as vaccine adjuvant". Research in Immunology 149, n.º 1 (janeiro de 1998): 37–39. http://dx.doi.org/10.1016/s0923-2494(98)80041-2.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

36

Rowe, PaulM. "Cautious optimism over interleukin-12". Lancet 345, n.º 8962 (junho de 1995): 1432. http://dx.doi.org/10.1016/s0140-6736(95)92618-6.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

37

Trinchieri, Giorgio, Manthrasalam Rengaraju, Annalisa D'Andrea, Nicholas M. Valiante, Marek Kubin, Miguel Aste e Jihed Chehimi. "Producer cells of interleukin-12". Immunology Today 14, n.º 5 (maio de 1993): 237–38. http://dx.doi.org/10.1016/0167-5699(93)90173-i.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

38

MA, XIAOJING, MIGUEL ASTE-AMEZAGA e GIORGIO TRINCHIERI. "Regulation of Interleukin-12 Production". Annals of the New York Academy of Sciences 795, n.º 1 Interleukin 1 (outubro de 1996): 13–25. http://dx.doi.org/10.1111/j.1749-6632.1996.tb52651.x.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

39

BLISS, JUDY, RICHARD MAYLOR, KEYA STOKES, KRISTIN S. MURRAY, MARA A. KETCHUM e STANLEY F. WOLF. "Interleukin-12 as Vaccine Adjuvant." Annals of the New York Academy of Sciences 795, n.º 1 Interleukin 1 (outubro de 1996): 26–35. http://dx.doi.org/10.1111/j.1749-6632.1996.tb52652.x.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

40

Brunda, Michael J., e Maurice K. Gately. "Antitumor Activity of Interleukin-12". Clinical Immunology and Immunopathology 71, n.º 3 (junho de 1994): 253–55. http://dx.doi.org/10.1006/clin.1994.1081.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

41

Karp, Christopher L. "Interleukin-12: Amiss in MS". Annals of Neurology 45, n.º 6 (junho de 1999): 689–92. http://dx.doi.org/10.1002/1531-8249(199906)45:6<689::aid-ana1>3.0.co;2-m.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

42

Podlaski, Frank J., Venkata B. Nanduri, Jeffrey D. Hulmes, Yu-Ching E. Pan, Wayne Levin, Waleed Danho, Richard Chizzonite, Maurice K. Gately e Alvin S. Stern. "Molecular characterization of interleukin 12". Archives of Biochemistry and Biophysics 294, n.º 1 (abril de 1992): 230–37. http://dx.doi.org/10.1016/0003-9861(92)90162-p.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

43

Trinchieri, Giorgio, Manthrasalam Rengaraju, Annalisa D'Andrea, Nicholas M. Valiante, Marek Kubin, Miguel Aste e Jihed Chehimi. "Producer cells of interleukin 12". Parasitology Today 9, n.º 3 (março de 1993): 97. http://dx.doi.org/10.1016/0169-4758(93)90215-2.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

44

Gately, Maurice K., Louis M. Renzetti, Jeanne Magram, Alvin S. Stern, Luciano Adorini, Ueli Gubler e David H. Presky. "THE INTERLEUKIN-12/INTERLEUKIN-12-RECEPTOR SYSTEM: Role in Normal and Pathologic Immune Responses". Annual Review of Immunology 16, n.º 1 (abril de 1998): 495–521. http://dx.doi.org/10.1146/annurev.immunol.16.1.495.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

45

Wang, Xin, Victoria L. Wilkinson, Frank J. Podlaski, Chang-you Wu, Alvin S. Stern, David H. Presky e Jeanne Magram. "Characterization of mouse interleukin-12 p40 homodimer binding to the interleukin-12 receptor subunits". European Journal of Immunology 29, n.º 6 (junho de 1999): 2007–13. http://dx.doi.org/10.1002/(sici)1521-4141(199906)29:06<2007::aid-immu2007>3.0.co;2-0.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

46

Yücel, Özlem Özer, Ezel Berker, Semra Gariboğlu e Harika Otlu. "Interleukin-11, interleukin-1β, interleukin-12 and the pathogenesis of inflammatory periodontal diseases". Journal of Clinical Periodontology 35, n.º 5 (maio de 2008): 365–70. http://dx.doi.org/10.1111/j.1600-051x.2008.01212.x.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

47

GATELY, MAURICE K., DAISY M. CARVAJAL, SUZANNE E. CONNAUGHTON, SILKE GILLESSEN, RAJEEV R. WARRIER, KENNETH D. KOLINSKY, VICTORIA L. WILKINSON et al. "Interleukin-12 Antagonist Activity of Mouse Interleukin-12 p40 Homodimer in Vitro and in Vivo". Annals of the New York Academy of Sciences 795, n.º 1 Interleukin 1 (outubro de 1996): 1–12. http://dx.doi.org/10.1111/j.1749-6632.1996.tb52650.x.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

48

Robinson, Cory M., e Gerard J. Nau. "Interleukin‐12 and Interleukin‐27 Regulate Macrophage Control ofMycobacterium tuberculosis". Journal of Infectious Diseases 198, n.º 3 (agosto de 2008): 359–66. http://dx.doi.org/10.1086/589774.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

49

Kovarik, Johannes J., Elisabeth Kernbauer, Markus A. Hölzl, Johannes Hofer, Guido A. Gualdoni, Klaus G. Schmetterer, Fitore Miftari et al. "Fasting metabolism modulates the interleukin-12/interleukin-10 cytokine axis". PLOS ONE 12, n.º 7 (24 de julho de 2017): e0180900. http://dx.doi.org/10.1371/journal.pone.0180900.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

50

El-Shabrawi, Y. "Interleukin-12 und Interleukin-10 in intraokulären Flüssigkeiten von Uveitispatienten". Spektrum der Augenheilkunde 13, n.º 1 (fevereiro de 1999): 1–5. http://dx.doi.org/10.1007/bf03162708.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

Artigos de revistas sobre o tema "Interleukin-12"

Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos